Metastatic Colorectal Cancers Completed Phase 3 Trials for Cetuximab (DB00002)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00252564Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal CancerTreatment
NCT01228734A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type PatientsTreatment
NCT01001377ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerTreatment
NCT01878422Sequential Treatment Strategy for Metastatic Colorectal CancerTreatment
NCT00145314FLOX in Combination With Cetuximab in First-line Treatment of Colorectal CancerTreatment
NCT01030042Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic PatientsTreatment